Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.
about
Chemotherapy for advanced non-small cell lung cancer in the elderly populationRandomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803).Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.Taxanes for advanced non-small cell lung cancer.Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.Comprehensive Analysis of the Incidence and Survival Patterns of Lung Cancer by Histologies, Including Rare Subtypes, in the Era of Molecular Medicine and Targeted Therapy: A Nation-Wide Cancer Registry-Based Study From Taiwan.Non-platinum doublets were as effective as platinum-based doublets for chemotherapy-naïve advanced non-small-cell lung cancer in the era of third-generation agents.Is gemcitabine cost effective in cancer treatment?Taxol(®)-induced phosphatidylserine exposure and microvesicle formation in red blood cells is mediated by its vehicle Cremophor(®) EL.Influence of histological type, smoking history and chemotherapy on survival after first-line therapy in patients with advanced non-small cell lung cancer.
P2860
Q24186466-2D827313-A661-4840-8983-F2605D101BF7Q33358448-2EF705AB-A2D9-4FFE-87EA-6D8551C91DB8Q33367325-57E488F2-D0C5-4DCF-8820-B25BF27BA2B1Q35020524-E085A83A-D92B-4E3A-8D2E-37283285FC59Q35537773-3ACC9BB4-3015-4451-A0CB-82AE9775A063Q36194473-8E1C6CAE-4B7C-4D59-A859-C7AC718DBA67Q38032176-E057D7F6-59C1-487A-B85A-FBBE5886F0C2Q43042833-3E594873-A126-48C6-91BB-98A29A331DAEQ50495644-9F2A4003-14FB-4D51-98EA-798A18CCE47AQ51770090-3D106F77-E13E-451E-A8C7-8DA98C2A6C77
P2860
Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Paclitaxel plus carboplatin, c ...... g cancer previously untreated.
@ast
Paclitaxel plus carboplatin, c ...... g cancer previously untreated.
@en
type
label
Paclitaxel plus carboplatin, c ...... g cancer previously untreated.
@ast
Paclitaxel plus carboplatin, c ...... g cancer previously untreated.
@en
prefLabel
Paclitaxel plus carboplatin, c ...... g cancer previously untreated.
@ast
Paclitaxel plus carboplatin, c ...... g cancer previously untreated.
@en
P2093
P2860
P356
P1433
P1476
Paclitaxel plus carboplatin, c ...... g cancer previously untreated.
@en
P2093
J Whang-Peng
P2860
P304
P356
10.1093/ANNONC/MDF009
P577
2002-01-01T00:00:00Z